Esperienze
Il Dott. Agostino Paoletta è specialista in Endocrinologia.
Si occupa, in particolar modo, di tumori ipofisari, malattie del surrene, noduli tiroidei, sindrome dell’ovaio policistico, malattie della tiroide e obesità.
Il Dott. Paoletta, laureato nel 1988 in Medicina e Chirurgia presso l’Università degli Studi di Padova, si specializza in Endocrinologia e Malattie del Ricambio presso la medesima università nel 1993. Inoltre, consegue un Dottorato di Ricerca in Scienze Endocrine presso l’Università degli Studi di Padova nel 1997 ed è stato Assegnista di Ricerca in Endocrinologia presso la stessa università fra il 1998 e il 2001.
Nel 1987 è stato Medico frequentatore del Dipartimento di Fisiologia della Scuola di Medicina Interna presso l’Università di San Francisco (U.C.S.F.- California-USA) occupandosi del meccanismo d’azione dei glucocorticoidi e della patogenesi dei tumori ipofisari.
Attualmente, il Dott. Paoletta è Medico specialista ambulatoriale (SAI) nella branca di endocrinologia e diabetologia presso la ULSS 6 Euganea di Padova. Inoltre, svolge la sua attività come libero professionista presso vari studi privati di Camposampiero, Padova e Tezze sul Brenta.
È autore di pubblicazioni scientifiche nazionali ed internazionali e vanta la partecipazione a congressi e convegni in Italia e all’estero. Ha, infine, partecipato come relatore a svariati Corsi di Formazione Continua post-Specialistica.
Altro
Su di me
Si occupa, in particolar modo, di tumori ipofisari, malattie del surrene, noduli tiroidei, sindrome dell’ovaio policistico, malattie della tiroide e obesità.
Il Dott. Paoletta, laureato nel 1988 in Medicina e Chirurgia presso l’Università degli Studi di Padova, si specializza in Endocrinologia e Malattie del Ricambio presso la medesima università nel 1993. Inoltre, consegue un Dottorato di Ricerca in Scienze Endocrine presso l’Università degli Studi di Padova nel 1997 ed è stato Assegnista di Ricerca in Endocrinologia presso la stessa università fra il 1998 e il 2001.
Nel 1987 è stato Medico frequentatore del Dipartimento di Fisiologia della Scuola di Medicina Interna presso l’Università di San Francisco (U.C.S.F.- California-USA) occupandosi del meccanismo d’azione dei glucocorticoidi e della patogenesi dei tumori ipofisari.
Attualmente, il Dott. Paoletta è Medico specialista ambulatoriale (SAI) nella branca di endocrinologia e diabetologia presso la ULSS 6 Euganea di Padova. Inoltre, svolge la sua attività come libero professionista presso vari studi privati di Camposampiero, Padova e Tezze sul Brenta.
È autore di pubblicazioni scientifiche nazionali ed internazionali e vanta la partecipazione a congressi e convegni in Italia e all’estero. Ha, infine, partecipato come relatore a svariati Corsi di Formazione Continua post-Specialistica.
Aree di competenza principali:
- Diabetologia
- Endocrinologia
Principali patologie trattate
- Tiroidite di hashimoto ,
- Obesità ,
- Tumore della tiroide ,
- Ipogonadismo ,
- Policistosi ovarica ,
- +3 a11y_sr_more_diseases
Esperienze
Agostino Paoletta
endocrinologo, diabetologo
Patologie trattate
- Tiroidite di hashimoto
- Obesità
- Tumore della tiroide
- Ipogonadismo
- Policistosi ovarica
- Noduli tiroidei
- Ipotiroidismo-Ipertiroidismo
- Malattie dell'ipofisi
Pubblicazioni
- The existence of feedback inhibition of ACTH on its own secretion has been postulated. To investigate its existence in man, the effects of synthetic ACTH 1-24 on endogenous ACTH secretion were tested in 13 patients with Addison's disease. Plasma ACTH was measured using an immunoradiometric assay, specific for endogenous ACTH 1-39. Ten patients were...
- F Mantero
- Agostino Paoletta[...]
- N Sonino
- Marco Boscaro Md
- Mar 1988
- Article
- Evidence for UltraShort Loop Autoregulation of Adrenocorticotropin Secretion in Man
- View
- Previous reports have emphasized the value of bilateral and simultaneous catheterization of the inferior petrosal sinus for the measurement of both basal and oCRH (ovine Corticotropin Releasing Hormone) stimulated ACTH levels to determine the site of the microadenoma in the pituitary and for the differential diagnosis of Cushing's disease. This met...
- G Giacomazzo
- Agostino Paoletta
- A Rampazzo
- Apr 1989
- Article
- [Use of catheterization of the inferior petrosal sinus in the diagnosis of Cushing's disease]
- View
- β-Endorphin and ACTH are secreted concomitantly in baseline conditions and in response to physiological and pharmacological stimuli. However, few and contradictory data are available on their feedback inhibition mechanisms. To investigate this aspect, the effects of exogenous ACTH1–24 and glucocorticoids on endogenous ACTH1–39 and β-endorphin were...
- Nicoletta Sonino
- Peter Giacomazzi[...]
- Agostino Paoletta
- Marco Boscaro Md
- May 1990
- Article
- Inhibition of Pituitary β-Endorphin by ACTH and Glucocorticoids
- View
- Ketoconazole treatment of Cushing's syndrome has been reported in single cases and a few small groups of 5-8 patients. We report our experience in 34 patients. Clinical study, with pretreatment and post-treatment evaluations. Out of 67 patients with Cushing's syndrome admitted during the last 6 years, 34 (28 females/six males; age range 14-67 years...
- D Ziliotto
- Agostino Paoletta[...]
- Marco Boscaro Md
- Nicoletta Sonino
- Nov 1991
- Article
- Ketoconazole treatment in Cushing's syndrome: Experience in 34 patients
- View
- A short-loop autoregulation of ACTH has been hypothesized. In 4 normal subjects after metyrapone and in 4 Addisonian patients, ACTH (1-39) measured by immunoradiometric assay decreased immediately after ACTH (1-24) bolus, due to artifactual effect. However, it remained significantly lower than in the control day after disappearance of circulating A...
- N. Sonino
- Fortunato Pesarin[...]
- Agostino Paoletta
- Marco Boscaro Md
- Jan 1992
- Article
- Evidence for short-loop autoregulation of adrenocorticotropin in man by immunoradiometric- and radioimmuno- assays
- View
- Bilateral simultaneous inferior petrosal sinus sampling, associated with the oCRH stimulation test (100 micrograms i.v. as a bolus) was performed in 22 patients with Cushing's syndrome and no signs of pituitary abnormalities. Catheters were inserted into both femoral veins. More than one site in the superior and inferior vena cava was sampled befor...
- Nicoletta Sonino
- Agostino Paoletta[...]
- Annalisa Rampazzo
- Marco Boscaro Md
- Apr 1992
- Article
- Selective Venous Sampling in the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome
- View
- To evaluate the effect of conventional antihypertensive drugs and/or inhibitors of steroid production in the management of hypertension in Cushing's syndrome. A retrospective open clinical study with pre- and post-treatment assessment. A university hospital, where patients were initially admitted and then followed-up in an ambulatory clinic over a...
- Nicoletta Sonino
- Francesco Tona[...]
- Agostino Paoletta
- Francesco Fallo
- Jan 1994
- Article
- Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing’s sindrome
- View
- Idiopathic Addison's disease occurs frequently in association with other organ-specific autoimmune diseases, and autoantibodies to adrenal cortex are markers of this condition. A variable asymptomatic period with subtle adrenal dysfunction may precede the onset of clinical manifestations. We studied the pituitary-adrenal axis by measuring plasma AC...
- F Fallo
- N Sonino[...]
- C Betterle
- Marco Boscaro Md
- Aug 1994
- Article
- Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency
- View
- The most common lesion in Cushing’s disease is an anterior pituitary adenoma. However, normal or hyperplastic corticotropic pituitary tissue has also been found in some cases. In an attempt to distinguish the patterns of ACTH response to oCRH in different forms of anterior pituitary hypersecretion, 17 patients with pituitary adenoma and 17 without...
- Nicoletta Sonino
- Agostino Paoletta[...]
- Annalisa Rampazzo
- Marco Boscaro Md
- Sep 1994
- Article
- Patterns of ACTH Response to oCRH in Cushing’s Disease: Correlation with Histological/Immunocytochemical Findings
- View
- Idiopathic Addison's disease occurs frequently in association with other organ-specific autoimmune diseases, and autoantibodies to adrenal cortex are markers of this condition. A variable asymptomatic period with subtle adrenal dysfunction may precede the onset of clinical manifestations. We studied the pituitary-adrenal axis by measuring plasma AC...
- Francesco Fallo
- N Sonino[...]
- C Betterle
- Marco Boscaro Md
- Sep 1994
- Article
- Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency
- View
- The effect of a surgical cure of hypercortisolism on hypertension in 54 patients with Cushing’s syndrome was assessed. The correlation between preoperative duration of hypertension and posttreatment blood pressure was significant (P
- Marco Boscaro Md
- Luisa Barzon[...]
- Nicoletta Sonino
- Francesco Fallo
- Jan 1996
- Article
- Effect of Surgical Treatment on Hypertension in Cushing’s Syndrome
- View
- N. Sonino
- E. Scarpa[...]
- Marco Boscaro Md
- Agostino Paoletta
- Nov 1997
- Article
- Evidence for age-related changes in fast-feedback corticotropin inhibition by glucocorticoids in man
- View
- A decrease in hypothalamic-pituitary-adrenal axis sensitivity to glucocorticoid feedback suppression seems to occur with aging. To investigate possible abnormalities in the inhibitory effect of glucocorticoids on ACTH secretion in the elderly, we evaluated the endogenous ACTH response to hydrocortisone (25 mg as an i.v. bolus) in 15 healthy aged (6...
- Nicoletta Sonino
- Elena Scarpa[...]
- Agostino Paoletta
- Marco Boscaro Md
- Apr 1998
- Article
- Age-Related Changes in Glucocorticoid Fast Feedback Inhibition of Adrenocorticotropin in Man 1
- View
- The natural course of adrenal incidentalomas and the risk that such lesions evolve toward hormonal hypersecretion or malignancy are still under evaluation. Of 246 consecutive patients with adrenal incidentaloma studied at our institution in the last 15 yr, 91 underwent surgery. Of the remaining patients, a group of 75 (52 females and 23 males; medi...
- Marco Boscaro Md
- Nicoletta Sonino[...]
- Carla Scaroni
- Luisa Barzon
- Feb 1999
- Article
- Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas 1
- View
- It is not known whether medical treatment to lower growth hormone (GH) and insulin-like growth factor (IGF)-1 levels may improve the compromised quality of life of patients with acromegaly. We studied the effects on quality of life of the slow-release somatostatin analogue lanreotide, 30 mg i.m., every 14 days for 2 months in 10 patients with activ...
- Marco Boscaro Md
- Agostino Paoletta[...]
- E Scarpa
- Nicoletta Sonino
- Feb 1999
- Article
- Slow-Release Lanreotide Treatment in Acromegaly: Effects on Quality of Life
- View
- The natural course of adrenal incidentalomas and the risk that such lesions evolve toward hormonal hypersecretion or malignancy are still under evaluation. Of 246 consecutive patients with adrenal incidentaloma studied at our institution in the last 15 yr, 91 underwent surgery. Of the remaining patients, a group of 75 (52 females and 23 males; medi...
- Marco Boscaro Md
- Nicoletta Sonino[...]
- Carla Scaroni
- Luisa Barzon
- Mar 1999
- Article
- Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas 1
- View
- The purpose of the study was to assess the frequency and characteristics of psychological distress, even after adequate treatment, in the heterogeneous population of an endocrine outpatient clinic. 146 endocrine patients (31 males/115 females; age 39.4 +/- 12.5 years), who were cured or in remission, were studied in a university endocrine outpatien...
- Giovanni A Fava
- Chiara Ruini[...]
- Cecilia Navarrini
- Nicoletta Sonino
- Feb 2004
- Article
- Persistent Psychological Distress in Patients Treated for Endocrine Disease
- View
- Glucocorticoids were found to inhibit adiponectin gene expression and secretion both in vitro and in animal models. We evaluated first the acute effect of i.v. glucocorticoids on adiponectin in normal subjects and secondly plasma adiponectin levels in a series of patients with Cushing's syndrome compared with controls. Hydrocortisone (25 mg) was ad...
- Roberto Vettor
- Nicoletta Sonino[...]
- Alessando Scarda
- Francesco Fallo
- Mar 2004
- Full-text available
- Article
- Effect of glucocorticoids on adiponectin: A study in healthy subjects and in Cushing's syndrome
- Figure 3 Relationship between urinary cortisol and plasma adiponectin...
- Figure 2 Individual data of plasma adiponectin in obese Cushing's...
- Table 1 Details of patients and controls included in the study.
- View
- To verify whether patients with pituitary disorders in remission and on appropriate treatment display significant differences in psychological distress compared to healthy controls and other patients treated for nonpituitary endocrine disorders. A single-centred, controlled study. Eighty-six outpatients cured or in remission for at least 9 months f...
- Giovanni A Fava
- Cecilia Navarrini[...]
- Chiara Ruini
- Nicoletta Sonino
- Nov 2007
- Article
- Psychosocial impairment in patients treated for pituitary disease: A controlled study
- View
- A large body of in vitro evidence shows that cytokines influence the hypothalamic-pituitary-adrenal axis both in physiological conditions and in Cushing's disease (CD). In order to study in vivo the role of intrapituitary cytokines in CD, we assayed two cytokines known for their action on the pituitary, i.e. interleukin-1 beta (IL-1β) and interleuk...
- Giacomo Tirabassi
- Roberta Papa[...]
- Giorgio Arnaldi
- Agostino Paoletta
- Dec 2010
- Article
- Intrapituitary cytokines in Cushing's disease: Do they play a role?
- View
- Acromegaly is associated with increased cardiovascular morbidity and mortality and with specific heart and vascular abnormalities. The aim of our study was to investigate arterial stiffness using the ambulatory arterial stiffness index (AASI) and symmetric AASI (Sym-AASI), two indexes derived from 24-h ambulatory blood pressure monitoring (ABPM), i...
- Pietro Maffei
- Renzo Carretta[...]
- Andrea Grillo
- Francesca Dassie
- Nov 2011
- Full-text available
- Article
- Ambulatory arterial stiffness indexes in acromegaly
- linear regression analysis showing the association of ambulatory...
- Figure 1 Box plots including lower and upper quartiles, median (50th...
- View
- The aim of the study was to evaluate patients with Cushing's syndrome the coronary flow reserve (CFR), an index of coronary microvascular function. Fifteen newly diagnosed patients with Cushing's syndrome (1 male/14 females; mean age 45 ± 11 years), were selected for having no clinical evidence of ischemic heart disease. Twelve patients had pituita...
- Francesco Tona
- Dario Capizzi[...]
- Giulia Famoso
- Francesco Fallo
- Aug 2012
- Article
- Coronary microvascular function in patients with Cushing's syndrome
- View
- La prescrizione off-label dei farmaci è un tema di solito trattato da farmacologi o legali. Per recuperare la dovuta attenzione dei medici è invece necessario ricordare che la sicurezza del paziente rappresenta la storica “mission” della professione medica. Solo spronando tale orgoglio culturale si può pensare di recuperare il senso e l’applicazion...
- Pietro Maffei
- Agostino Paoletta[...]
- Chiara Martini
- Nicola Sicolo
- Apr 2013
- Article
- Farmaci off-label in endocrinologia clinica: rischi e aspetti regolatori
- View
- The optimal method of assessing GH status in acromegalic patients receiving medical therapy with somatostatin analogs (SSA) has been matter of debate. The aim of the study has been to investigate whether OGTT may add information in patients with discordant random GH (GHr) and IGF values. Moreover, we evaluated the association of GH nadir with the p...
- Massimo Terzolo
- Maria Rosaria Ambrosio[...]
- Marta Bondanelli
- Giuseppe Reimondo
- Jun 2013
- Full-text available
- Article
- Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment
- Table 1 Comparison of demographic and clinical characteristics among...
- View
- Cushing's syndrome is associated with high cardiovascular morbility and mortality. Blood pressure (BP) variability within a 24-h period is increasingly recognized as an independent predictor of cardiovascular risk. The aim of our study was to investigate the short-term BP variability indices in Cushing's syndrome. Twenty-five patients with Cushing'...
- Francesco Fallo
- Francesca Dassie[...]
- Andrea Grillo
- Andrea Rebellato
- Jan 2014
- Full-text available
- Article
- Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome
- View
- Background: Cardiovascular complications, including arrhythmias and cardiac sudden death, are the most common causes of enhanced mortality in acromegaly. However, few data are available on cardiac autonomic functions and sympathovagal balance in acromegalic patients. Objective: The aim of this study was to investigate both the time and frequency...
- P Maffei
- Chiara Martini[...]
- F Dassie
- A Comunello
- Sep 2014
- Full-text available
- Article
- Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues
- View
- To the Editor,The literature reports steroid-responsive diseases co-existing with Cushing’s syndrome, which fully develop after remission of endogenous hypercortisolism. They mainly include autoimmune or allergic diseases [1]. We describe a case of nephrotic syndrome, diagnosed during work-up for Cushing’s disease, and subsequently unmasked by succ...
- Francesco Fallo
- Billeci Domenico
- Agostino Paoletta
- Oct 2014
- Article
- A case of nephrotic syndrome hidden by Cushing’s disease
- View
- Background: A significant number of patients show sub-optimal adherence to levothyroxine (LT4) therapy, mainly because they have to postpone their breakfast by at least 30 min. The aim of this observational cross-sectional study was to assess the therapeutic compliance of patients on LT4 treatment and to verify the preference of a lifetime treatmen...
- Maurizio Castellano
- Fiorella Marini[...]
- Roberto Castello
- Carlo Cappelli
- Nov 2018
- Full-text available
- Article
- Adherence to Levothyroxine Treatment Among Patients With Hypothyroidism: A Northeastern Italian Survey
- FIGURE 1 | Medication preference for tablet and liquid LT4 formulations...
- View
- Alessandro Scoppola
- Borretta Giorgio[...]
- Olga Eugenia Disoteo
- Marco Chianelli
- May 2022
- Article
- Attitude of Italian endocrinologists towards obesity management. Results of a survey with 534 respondents
- View
- Marco Chianelli
- Robertoi Vettor[...]
- Luca Busetto
- Michela Cinquini
- Jan 2023
- Preprint
- Efficacy of Anti-Obesity Drugs and Metabolic Surgeries as Add-On to Lifestyle Intervention in Obesity with Metabolic Complications: A Network Metanalysis
- View
- Introduction Obesity is a global pandemic and is cause of serious concern in all regions of the world. It is important to raise the attention of health care professionals in order to provide early treatment of patients with obesity. Obesity management, however, varies greatly amongst endocrinologists with respect to attitudes to diagnosis and treat...
- Antonio Nicolucci
- Roberto Attanasio[...]
- Luca Busetto
- Marco Chianelli
- Jan 2023
- Full-text available
- Article
- Obesity management: Attitudes and practice of Italian endocrinologists
- +1Reported percentage of patients to whom psychological support should be...
- Rate of prescription of different anti-obesity drugs by respondent...
- Characteristics of respondents.
- TABLE 7 Continued
- TABLE 1 Continued
- View
- Aim: This guideline (GL) is aimed at providing a reference for the management of non-functioning, benign thyroid nodules causing local symptoms in adults outside of pregnancy. Methods: This GL has been developed following the methods described in the Manual of the National Guideline System. For each question, the panel appointed by Associazione...
- Roberto Attanasio
- Annamaria D'Amore[...]
- Anna Crescenzi
- Enrico Papini
- Feb 2023
- Article
- Italian Guidelines For The Management Of Non-Functioning Benign And Locally Symptomatic Thyroid Nodules
- View
- Roberto Attanasio
- De Menis Ernesto Pasquale[...]
- Renata Simona Auriemma
- Renato Cozzi
- May 2023
- Article
- Italian guidelines for the management of prolactinomas
- View
- Marco Chianelli
- Roberto Attanasio[...]
- Agnese Persichetti
- Irene Samperi
- May 2023
- Article
- Therapy of overweight and obesity resistant to behavioral treatment in the adult population with metabolic comorbidities. A network meta-analysis
- View
- Introduction: This guideline (GL) is aimed at providing a reference for the management of prolactin (PRL)-secreting pituitary adenoma in adults. However, pregnancy is not considered. Methods: This GL has been developed following the methods described in the Manual of the Italian National Guideline System. For each question, the panel appointed b...
- Roberto Attanasio
- Ernesto De Menis[...]
- Renata Simona Auriemma
- Renato Cozzi
- May 2023
- Full-text available
- Article
- Italian Guidelines for the Management of Prolactinomas
- Results of cost-efficacy analysis for therapeutic actions.
- Costs of therapeutic procedures -macroprolactinoma.
- Costs of therapeutic procedures -microprolactinoma.
- Common PRL-rising medications.
- View
- Enrico Papini
- alessandro scoppola[...]
- Michele Basile
- Irene Samperi
- Aug 2023
- Article
- A pharmacoeconomic analysis from italian guidelines for the management of non-hyperfunctioning, bening thyroid nodules
- View
- Enrico Papini
- Alessandro Scoppola[...]
- Michele Basile
- Roberto Novizio
- Aug 2023
- Article
- Italian guideline on the management of benign non-hyperfunctioning thyroid nodule causing compressive symptoms
- View
- Aim: This guideline (GL) is aimed at providing a clinical practice reference for the management of sporadic primary hyperparathyroidism (PHPT) in adults. PHPT management in pregnancy was not considered. Methods: This GL has been developed following the methods described in the Manual of the Italian National Guideline System. For each question, the...
- Roberto Attanasio
- Iacopo Chiodini[...]
- Giorgio Borretta
- Fabio Vescini
- Dec 2023
- Article
- Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism
- View
- Background Prolactinoma, the most common pituitary adenoma, is usually treated with dopamine agonist (DA) therapy like cabergoline. Surgery is second-line therapy, and radiotherapy is used if surgical treatment fails or in relapsing macroprolactinoma. Objective This study aimed to provide economic evidence for the management of prolactinoma in Ita...
- Americo Cicchetti
- Roberto Attanasio[...]
- Ilaria Valentini
- Michele Basile
- Jan 2024
- Full-text available
- Article
- A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
- View
- This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification. Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a general practitioner, a nutritionist, a nurse...
- Roberto Attanasio
- R Vettor[...]
- Luca Busetto
- M Chianelli
- Apr 2024
- Article
- Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment
Formazione
- Università degli Studi di Padova
Indirizzi (8)
Via Tiziano Aspetti 106, Padova 35133
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Via T. Aspetti 106, Padova 35133
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
via Borgo Padova 106/1, Camposampiero 35012
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Via Maestro Antonio Ceccon 2, Loreggia 35010
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Via Nazionale 128, Belvedere 36056
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Via Leonardo da Vinci 38, Campo San Martino 35010
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
P.le jutificio 22, Piazzola sul Brenta 35016
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Disponibilità
Questo dottore non offre prenotazioni online a questo indirizzo
Pazienti accettati
- Pazienti senza assicurazione sanitaria
Prestazioni e prezzi
-
Consulenza online
75 € -
-
Prima visita endocrinologica
150 € -
-
Visita endocrinologica
110 € - 150 € -
-
Visita endocrinologica di controllo
110 € -
Recensioni
3 recensioni
Tutte le recensioni contano e non possono essere rimosse o modificate dai dottori a proprio piacimento.
Scopri come funziona il processo di moderazione delle recensioni.
Per saperne di più sulle opinioni
-
K
K.F.
Grande professionalità. Molto chiaro nelle spiegazioni.
Consigliato.• Poliambulatorio San Polo • prima visita endocrinologica •
-
D
D.V.
Ho riscontrato attenzione durante la prima visita.
• Donna Più Poliambulatorio specialistico • prima visita endocrinologica •
-
M
Maria Luisa P.
Mi sono trovata benissimo con il dottor Paoletta. Grande professionista e grande empatia
• Consulenza online • consulenza online •